Long-term risk to children’s health unknown
Monday, July 23, 2007 by: Mike Adams
New research published in the August, 2007 issue of the Journal of the American Academy of Child and Adolescent Psychiatry finds that Ritalin, the amphetamine drug used to treat a fictitious medical disorder labeled Attention Deficit Hyperactivity Disorder, stunts the growth of children. After three years on the psychotropic drug, children are one inch shorter and 4.4 pounds lighter than their peers, researchers have documented.ÂÂ
The psychiatric industry, of course, has been trying to play down the growth-stunting effects of Ritalin for at least a decade. Research conducted over the last several years by psychiatrists working for the National Institutes of Health initially found evidence of the drug stunting growth of children, yet nevertheless concluded that Ritalin carries “no long-term growth risk” to children. (Those researchers, by the way, failed to disclose their financial conflicts of interest with drug companies.) Because of that conclusion, psychiatrists have refrained from warning parents about the fact that Ritalin stunts the growth of their children, focusing instead of how their children need “treatment” to correct a “brain chemistry disorder” that was, in reality, invented by the Big Pharma-backed psychiatric industry as a way to sell more drugs to children who don’t need them.
Read the whole article at http://www.newstarget.com/021944.html